Microarray Analysis Market Research Report: By Technology (DNA Microarray, PCR, NGS, SAGE, and Northern Blotting), By Consumables (DNA Chips, DNA Microarrays, Protein Microarrays, Cellular Microarrays, Chemical Compound Microarrays, Antibody Microarrays and others), By Services (Gene Profiling and Bioinformatics) and By Applications (Research, Drug Discovery and Diagnostic) - Global Forecast till 2027
Abcam, Asterand Bioscience, IHC World, LLC, Novus Biologicals Llc (Acquired By Bio-Techne), Origene Technologies, Inc, Pantomics, Inc, Protein Biotechnologies Inc, US Biomax, Inc, Agilent Technologies, Illumina, Thermo Fisher Scientific, Merck are some of the prominent players at the forefront of competition in the Global Microarray Analysis Market and are profiled in MRFR Analysis.
Global Microarray Analysis Market - Overview
A microarray is a multiplex lab-on-a-chip. It is a 2D array on a solid substrate, usually a glass slide or silicon thin-film cell, that assays large amounts of biological material using high-throughput screening miniaturized, multiplexed and parallel processing and detection methods.
The concept and methodology of microarrays was first introduced and illustrated in antibody microarrays in 1983. With the establishment of companies, such as Affymetrix, Agilent, Applied Microarrays, Arrayit, Illumina, and others, the technology of DNA microarrays has become the most sophisticated and the most widely used. DNA microarrays are microscope slides that are printed with thousands of tiny spots in defined positions, with each spot containing a known DNA sequence or gene. Often, these slides are referred to as gene chips or DNA chips. The DNA molecules attached to each slide act as probes to detect gene expression, which is also known as the transcriptome or the set of messenger RNA (mRNA) transcripts expressed by a group of genes.
Globally the microarray market is dominated by DNA microarrays. The protein microarray is currently the fastest growing market. The use of peptide and carbohydrate microarrays is expanding. Tissue and cell microarrays are in their infancy stage and are developing slowly because of many complications in the process development
Further In the coming years, the global microarray market will advance more than it has in the past several years. DNA microarray is holding the large market share in the microarray industry. Initially it may take time for widespread growth of types like tissue and cellular microarray. But in the near future, as the research in this field progresses, tissue microarray will play an integral part in the diagnostic techniques in the field of cancer research and diagnosis.
Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/777
Market Gaps:
Tissue microarray is relatively new technique and a lot of research in tissue microarray is still going on. As the technique is in its infancy stage, lots of inaccuracies and errors occur. The readings are not accurate in most of the analysis. As the results are not reliable, it creates a hindrance in the growth of the tissue microarray method.
Besides this, microarrays are not recommended for certain types of studies. In certain tumours such as glioblastoma, there is such marked heterogeneity within tumours that this feature may not be adequately captured in microarray studies.
In addition, microarray analysis is not very useful to study rare or focal events, such as number of immune cells in tumours. It is difficult to study certain facets of tumour biology, such as interactions between the tumour and its stroma, as these stromal components may not be adequately represented in the cores.
Global Microarray Analysis Market - Competitive Analysis
Characterized by the presence of several well-established and small players, the global Market of Microarray Analysis seems to be highly competitive and fragmented. International players who are increasingly expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features such as product differentiation, product portfolios, quality, and pricing. The Market is witnessing strengthened competition which is anticipated to be more intensified further during the forecast period. The intense competition predominant in the market dictates the alliance and associations among marketers.
Well established and emerging players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.
For example,
Dated: June 2017, Agendia proclaimed a contract extension of its association with Agilent Technologies Inc. to develop an RNA sequencing-based version of its prevailing microarray-based MammaPrint and BluePrint tests. As a result of this contract extension the MammaPrint BluePrint Kit of Agendia’s portfolio will empower cancer centers to run the tests on their prevailing next-generation sequencing (NGS) instruments in their own laboratories. Thus performing the test locally bids superior access so that more patients can take advantage from the personalized treatment that these tests are capable of. Further the study will include UZ Leuven processing breast tumour samples from patients registered in the study using the NGS-based MammaPrint BluePrint Kit. The results of these patients will be directly associated with those from the presently marketed MammaPrint microarray-based test, executed at the Company’s Amsterdam CLIA-certified and CAP-accredited laboratory, to validate the comparability of the two technologies.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/global-microarray-analysis-market-777
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
Global Microarray Analysis Market: By Product& Services (Consumables, Software and Services, Others), By Type (DNA Microarrays, Protein Microarrays), By Application (Drug discovery, Disease Diagnostic, Research Applications), By End User (Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories), and by Region (Americas, Europe, Asia-Pacific, and Middle East & Africa)—Forecast till 2027Market HighlightsAccording to MRFR analysis, the global microarray analysis market is expected to register a CAGR of 7.76% from 2020 to 2027 and hold a value of USD 6,607.64 million by 2027.The global microarray analysis market is driven by several factors, such asthe increasing prevalence of cancer and the rising need for research in pharmaceutical industries.
For instance, in August 2019, Agilent Technologies acquired Lionheart Technologies LLC ("BioTek"), a recognized player globally in designing, manufacturing, and distributing innovative life science instrumentation.
Its comprehensive product line includes microplate readers, cell imaging systems, washers, automated incubators,dispensers, and stackers.Segment AnalysisThe global microarray analysis market is segmented based on product & services, type, application, and end user.
The global market based on the product & services has been segmented into consumables, software & services, and instruments.
On the basis of application, the market has been segmented into drug discovery, disease diagnostic, research applications, and others.
The market for the global microarray analysis, by end user, is bifurcated into research and academic institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and others.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/777Regional AnalysisThe global microarray analysis market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.On regional basis, the Americas is anticipated to dominate the global microarray analysis market.The Americas accounted for the largest market share in 2019 and is likely to continue to command the market during the forecast period due to the increasing adoption of new technologies and the presence of major players in the region.
UpMarketResearch offers a latest published report on “Global DNA Microarray Market Industry Analysis and Forecast 2018-2023” delivering key insights and providing a competitive advantage to clients through a detailed report.
Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Get FREE Exclusive PDF Sample Copy of This Report @ https://www.upmarketresearch.com/home/requested_sample/1858 The scope of the report extends from market scenarios to comparative pricing between major players, cost and profit of the specified market regions.
The generated report is firmly based on primary research, interviews with top executives, news sources and information insiders.
Region-wise Analysis Global DNA Microarray Market covers: • North America • Europe • China • Japan • Southeast Asia • India The Report covers in-depth analysis as follows: • Chapter 1 DNA Microarray Market Overview • Chapter 2 Global Economic Impact on DNA Microarray Industry • Chapter 3 Global DNA Microarray Market Competition by Manufacturers • Chapter 4 Global DNA Microarray Production, Revenue (Value) by Region (2013-2018) • Chapter 5 Global DNA Microarray Supply (Production), Consumption, Export, Import by Regions (2013-2018) • Chapter 6 Global DNA Microarray Production, Revenue (Value), Price Trend by Type • Chapter 7 Global DNA Microarray Market Analysis by Application • Chapter 8 Global DNA Microarray Manufacturers Analysis • Chapter 9 DNA Microarray Manufacturing Cost Analysis • Chapter 10 Industrial Chain, Sourcing Strategy and Downstream Buyers • Chapter 11 Marketing Strategy Analysis, Distributors/Traders • Chapter 12 Market Effect Factors Analysis • Chapter 13 Global DNA Microarray Market Forecast (2018-2023) Gain Full Access of DNA Microarray market industry analysis & forecast 2018-2023 along with complete TOC @ https://www.upmarketresearch.com/reports/Global-DNA-Microarray-Industry-Market-Analysis-Forecast-2018-2023 “Global DNA Microarray Market Industry Analysis and Forecast 2018-2023” report helps the clients to take business decisions and to understand strategies of major players in the industry.
The report also calls for market-driven results deriving feasibility studies for client needs.
The global microarray market size is expected to reach USD 7.44 billion by the year 2026, growing at a CAGR of 8.7%, according to a new report by Grand View Research, Inc. Market drivers propelling market growth include a global rise in cancer cases and a wide range of applications of microarrays in sequencing, genome mapping, personalized medicines, and others.
A rise in global R investments is also key in propelling growth as this would lead to a rise in the use of microarrays for research purposes to advance and improve in healthcare.Microarrays have a wide range of applications such as research applications, drug discovery, disease diagnosis, genomic and proteomic research, plant and food research, agricultural research, among other applications.
Recent advances in proteomics and genomics coupled with human genome sequencing have led to an increase in several screenable drug targets.
According to a report published by PNAS (Proceedings of the National Academy of Sciences of the United States of America), a miniature 3D cell culture microarray has been developed for high throughput toxicological assays.The introduction of various types of array platforms offered by leading companies is also another factor anticipated to boost market potential.
For instance, R Systems, a biological products company offers proteome profiler antibody array, a protein microarray used to measure over 119 proteins in one sample.
With the use of this product, laboratory technicians do not need any specialized equipment additionally eliminating the need for western blot experiments.In recent years, large scale market players have collaborated with small and medium scale companies to expand their existing product portfolio and geographical presence.
